Peptide compounds for treating refractory status epilepticus

Details for Australian Patent Application No. 2007260208 (hide)

Owner UCB Pharma GmbH

Inventors Stohr, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2007260208

PCT Pub. Number WO2007/144196

Priority 60/813,967 15.06.06 US; 06 013 655.3 30.06.06 EP

Filing date 15 June 2007

Wipo publication date 21 December 2007

Acceptance publication date 12 April 2012

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/144196 Priority application(s): WO2007/144196

25 November 2010 Alteration of Name

  The name of the applicant has been altered to UCB Pharma GmbH Amendments

12 April 2012 Application Accepted

  Published as AU-B-2007260208

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007260216-Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them

2007260207-Pharmaceutical composition with synergistic anticonvulsant effect